Here’s a bold statement: the most tedious, soul-crushing job in healthcare is about to get a major upgrade—thanks to artificial intelligence. But here’s where it gets controversial: what if the billions lost to claim denials aren’t just a cost of doing business, but a symptom of systemic neglect? Neal K. Shah, a healthcare researcher and author of the bestselling book Insured to Death, argues that clinics are treating denied claims like trash when they should be mining them for gold. And this is the part most people miss: these denials aren’t just paperwork—they’re actionable data that, when harnessed correctly, could turn financial losses into gains.
When Shah first stepped into the revenue cycle department of a midsize outpatient clinic in Raleigh, he wasn’t greeted by the expected piles of patient charts. Instead, he found a quiet crisis: bins overflowing with denial slips, staff frantically chasing payers on the phone, and an air of resigned frustration. This wasn’t just inefficiency—it was a growing systemic failure. Clinics, he realized, were treating claim denials as a nuisance rather than a treasure trove of insights. His research at the University of Pennsylvania and collaborative work with Duke Health had already shown him that this approach was costing clinics dearly.
Here’s the shocking part: the average claim denial rate in the U.S. hovers around 15%, with some payers pushing it even higher. That means one in every five claims is rejected, despite meticulous clinical documentation, prior authorizations, and eligibility checks. Worse, many of these denials are eventually overturned on appeal, meaning they should never have been denied in the first place. So why are clinics leaving money on the table? Shah’s answer is simple: they’re not leveraging their data.
At his startup, Counterforce Health, Shah and his team build predictive models to identify claim denial risks and create tools that help smaller clinics—those without massive revenue cycle teams—turn this data into action. The key? Viewing denials not as an accounting headache but as intelligence. Each denial carries valuable metadata: payer details, denial reasons, procedure codes, dates, and appeal outcomes. Yet, only a fraction of clinics analyze this information at scale. According to recent research, 69% of healthcare providers using AI solutions report reduced claim denials and improved resubmissions. The question is: why aren’t more clinics jumping on this bandwagon?
To thrive in an era of thin margins, clinics need to rethink their approach. Here’s how:
- Change the Workflow: Instead of manually appealing denials after they happen, use AI to flag high-risk claims before submission. For example, AI can identify eligibility mismatches or coding anomalies in real time, marking claims for appeal or corrective action.
- Build Feedback Loops: Collect denial reasons and tie them into payer-specific playbooks. Patterns will emerge—like a payer consistently rejecting a specific CPT code for a diagnosis—and analytics can guide corrective training.
- Scale the Machine: Smaller clinics can’t afford full appeals departments. The solution? Build an AI system that triages claims, generates appeal documentation, attaches supporting records, and routes high-value cases for human review. Research shows this reduces wasteful spending.
- Make It Boardroom Material: Denial rates shouldn’t be buried in back-office metrics. Elevate them to the C-suite, where they’re treated as a growth lever, not a cost center.
- Lean on Partnerships: For smaller clinics, accessing collective payer analytics and best practices through partnerships or aggregators can level the playing field. Shah’s work at Counterforce Health aims to democratize this access, so non-hospital-system clinics don’t have to start from scratch.
But here’s the real question: What if clinics could reduce their denial rate by just 5%? For many, that’s tens or hundreds of thousands of dollars annually. So why treat this as optional? The narrative that denials are inevitable—or someone else’s problem—is a script for failure. It’s time for clinic leaders to rewrite it.
AI isn’t a futuristic promise; it’s already transforming revenue cycle operations. Clinics that embrace AI-powered denial intelligence won’t just recover revenue—they’ll build resilience. And in a system where margins are shrinking and complexity is growing, resilience is everything. So, here’s the controversial question: Are clinics ready to stop chasing payers and start chasing intelligence? Or will they keep treating denials like garbage instead of gold? The choice could define their survival.
